ArticleClinical and experimental gastroenterology2009

Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's disease.

Glen A Doherty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.